The ICRP's biokinetic models for five tritium-labeled and five 14C-labeled compounds (not including radiopharmaceutical compounds and excepting carbon monoxide) incorporate a compartment representing the body carbon pool. Using the ICRP models, as coded into the Genmod-PC internal dosimetry code, higher dose coefficients are calculated for females than for ICRP's Reference Man. The ICRP's committed effective dose coefficients for the ingestion of tritiated water and organically bound tritium by the adult male are 1.8 x 10(-11) and 4.2 x 10(-11) Sv Bq(-1), respectively. Using the Genmod-PC code, the corresponding dose coefficients for the adult female are 2.2 x 10(-11) and 6.2 x 10(-11) Sv Bq(-1), which are 25% and 46% greater than the adult male's. Similarly, the ICRP's dose coefficient is 5.8 x 10(-10) Sv Bq(-11) for an intake of organically bound 14C by the adult male, and the estimated dose coefficient using Genmod is 54% greater for the adult female. The carbon retention half-time for an average adult female is calculated as 51 d and that for an average adult male, 38 d; the latter is similar to the carbon half-time of 40 d recommended by International Commission on Radiological Protection (ICRP). The longer turnover time of whole body carbon in females is one factor that causes the dose coefficients for females to be higher than those of males; a second factor is the smaller whole body mass of ICRP's Reference Woman compared to Reference Man.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00004032-200109000-00011 | DOI Listing |
Eur Radiol
January 2025
Department of Radiology, University of Groningen, University Medical Center of Groningen, Groningen, The Netherlands.
Objective: To evaluate the repeatability of AI-based automatic measurement of vertebral and cardiovascular markers on low-dose chest CT.
Methods: We included participants of the population-based Imaging in Lifelines (ImaLife) study with low-dose chest CT at baseline and 3-4 month follow-up. An AI system (AI-Rad Companion chest CT prototype) performed automatic segmentation and quantification of vertebral height and density, aortic diameters, heart volume (cardiac chambers plus pericardial fat), and coronary artery calcium volume (CACV).
Phys Med
January 2025
Department of Medical Physics, Faculty of Medicine, University of Crete, P.O. Box 2208, 71003 Iraklion, Crete, Greece.
Purpose: To investigate the performance of a machine learning-based segmentation method for treatment planning of gastric cancer.
Materials And Methods: Eighteen patients planned to be irradiated for gastric cancer were studied. The target and the surrounding organs-at-risk (OARs) were manually delineated on CT scans.
Pediatr Infect Dis J
December 2024
Department of Neurofarba, Meyer Children's University of Florence, Florence, Italy.
Background And Aims: The aim of this study was to assess the health-related quality of life (HRQL) of children with chronic hepatitis C (CHC) at 1 year after the effective treatment with sofosbuvir/velpatasvir (SOF/VEL).
Methods: All 50 patients treated for CHC with a fixed dose SOF/VEL in the noncommercial, nonrandomized, open-label PANDAA-PED study achieved sustained virologic response at 12 weeks after the end of treatment. Evaluation of HRQL at 1-year posttreatment was compared with the baseline (before the treatment) assessment.
J Psychopharmacol
January 2025
Psychiatric Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Objective: Therapeutic drug monitoring (TDM) indicators have been suggested to predict overall outcome responses to olanzapine (OLZ) treatments in terms of efficacy and metabolic syndrome. This study aimed to investigate whether paraoxonase-1 (PON-1) activity can be used to predict schizophrenia patient outcomes.
Methods: Schizophrenic patients ( = 50) aged between 20 and 65 years who received OLZ treatment were recruited, and their Positive and Negative Syndrome Scale scores, PON-1 activity, and olanzapine drug levels normalized by dose (OLZ/D) and its metabolite N-desmethyl-olanzapine (DMO), together with biochemical parameters, were determined.
Pharmaceutics
December 2024
Department of Psychiatry, Oxford University, Warneford Hospital, Oxford OX3 7JX, UK.
: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders. However, it has poor oral bioavailability. We investigated the effect of a novel lipid formulation on its absorption in humans and on its tissue distribution in mice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!